Offer - Urjas Oil for just ₹ 1
Xop CV 200 Mg/125 Mg Tablet is a prescription medicine that is available as a Tablet. Other than this, Xop CV 200 Mg/125 Mg Tablet has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Xop CV 200 Mg/125 Mg Tablet. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Besides the aforementioned side effects, there are other adverse effects of Xop CV 200 Mg/125 Mg Tablet as well, which are listed below. These side effects of Xop CV 200 Mg/125 Mg Tablet are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
Xop CV 200 Mg/125 Mg Tablet's effect during pregnancy is Mild and Moderate while nursing. It is important to know if Xop CV 200 Mg/125 Mg Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Xop CV 200 Mg/125 Mg Tablet related warnings section.
Individuals suffering from medical conditions like Jaundice must refrain from the use of Xop CV 200 Mg/125 Mg Tablet since this can cause severe adverse effects. The section on Xop CV 200 Mg/125 Mg Tablet contraindications lists all such conditions.
Additionally, Xop CV 200 Mg/125 Mg Tablet may also adversely react with other medicines. Refer to the list below for further details.
In addition to the above precautions for Xop CV 200 Mg/125 Mg Tablet, it is important to know that it is safe while driving, and is habit-forming.
Xop CV 200 Mg/125 Mg Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| Adult |
|
| Geriatric |
|
Is the use of Xop CV 200 Mg/125 Mg Tablet safe for pregnant women?
Xop CV rarely shows harmful effects in in pregnant ladies. Even if it does, the effects are mild
Is the use of Xop CV 200 Mg/125 Mg Tablet safe during breastfeeding?
Breastfeeding women may feel side effects of Xop CV. If you see any side effects, stop taking Xop CV immediately and talk to your doctor. Take Xop CV again, only after your doctor's advice.
What is the effect of Xop CV 200 Mg/125 Mg Tablet on the Kidneys?
There can be some harmful effects on your kidneys after taking Xop CV. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Xop CV 200 Mg/125 Mg Tablet on the Liver?
There may be an adverse effect on the liver after taking Xop CV. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Xop CV 200 Mg/125 Mg Tablet on the Heart?
Xop CV is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Xop CV 200 Mg/125 Mg Tablet unless your doctor advises you to do so -
Is this Xop CV 200 Mg/125 Mg Tablet habit forming or addictive?
Forming a habit of Xop CV 200 Mg/125 Mg Tablet has not been reported.
Interaction between Food and Xop CV 200 Mg/125 Mg Tablet
Taking Xop CV 200 Mg/125 Mg Tablet with food does not harm your health.
Interaction between Alcohol and Xop CV 200 Mg/125 Mg Tablet
Information about the interaction of Xop CV 200 Mg/125 Mg Tablet and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vantin® (cefpodoxime proxetil )
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-311
